Cargando…
Genome-wide CRISPR screening reveals ADCK3 as a key regulator in sensitizing endometrial carcinoma cells to MPA therapy
BACKGROUND: The effectiveness of conservative treatment of endometrial carcinoma (EC) with oral progesterone therapy, such as medroxyprogesterone acetate (MPA), can be blunted due to primary or acquired resistance, but the underlying mechanisms remain incompletely defined. METHODS: Genome-wide CRISP...
Autores principales: | Zhang, Zijing, Zhang, Meng, Zhou, Jingyi, Wang, Donglai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421920/ https://www.ncbi.nlm.nih.gov/pubmed/37402867 http://dx.doi.org/10.1038/s41416-023-02347-2 |
Ejemplares similares
-
Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
por: Cui, Yunxia, et al.
Publicado: (2021) -
ADCK1 is a potential therapeutic target of osteosarcoma
por: Zhuo, Bao-biao, et al.
Publicado: (2022) -
Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC
por: Zhang, Jin-zhi, et al.
Publicado: (2022) -
Drosophila ADCK1 is critical for maintaining mitochondrial structures and functions in the muscle
por: Yoon, Woongchang, et al.
Publicado: (2019) -
Early-onset of ADCK4 glomerulopathy with renal failure: a case report
por: Lolin, Ksenija, et al.
Publicado: (2017)